Case report: Changes in serum bevacizumab concentration in a hemodialysis patient with unresectable colorectal cancer treated with FOLFIRI plus bevacizumab

The global incidence of colorectal cancer (CRC) in patients receiving hemodialysis is steadily rising. However, current information on the clinical use of chemotherapy for patients undergoing hemodialysis with CRC is limited. Herein, we describe a clinical course of a 74-year-old patient undergoing...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Toshimitsu, Suzuki, Hiroyuki, Ushijima, Tomoyuki, Nagasu, Sachiko, Akagi, Yoshito, Kawaguchi, Takumi, Miwa, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468777/
https://www.ncbi.nlm.nih.gov/pubmed/36110939
http://dx.doi.org/10.3389/fonc.2022.947013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468777/
https://www.ncbi.nlm.nih.gov/pubmed/36110939
http://dx.doi.org/10.3389/fonc.2022.947013

Ejemplares similares